Looking Ahead to 2026: A Vizgen View from Our CEO

Dear Vizgen Family,  

At Vizgen, 2025 was one of both significant evolution and steadfastness.  We bolstered our protein and co-detection capabilities, successfully resolved our prior litigation and introduced new, class-leading chemistry.  At the same time, we moved – as always, with speed – with the same purpose, toward a future where disease is precisely mapped and paths to cures clearly charted.  

This combination of change and sustained commitment is, as announced today, now fueled by significant new capital from world-renowned investors.  Here, at the beginning of 2026, we open a new era at Vizgen.  It is an era we also mark the debut of our revamped website.  I invite you to experience it, whether your interest is in applications such as neuroscience, the capabilities of MERFISH 2.0, an expanded set of ADC markers, or in how Vizgen Lab Services can support you from discovery to development. 

In closing, I will mention something that matters deeply to us: your trust. Thank you for the trust you have placed in us throughout the past year. Your breakthroughs, your challenges, and your ambitions as reflected in the literature continue to inspire us and strengthen our resolve.   We know that such trust – whether through data quality, in-lab support, or beyond – must be earned each day.  We are committed to doing just that.  To this end, let me know how we’re doing and what more we can do to support your scientific success in 2026!  You can reach me here rob.carson@vizgen.com 

Yours, 

Rob Carson
CEO, Vizgen